(Q51592951)

7 April 2018

title

Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson's disease. (English)

1 reference

7 April 2018

1 reference

1 reference

1 reference

3

1 reference

7 April 2018

David Howells

8

1 reference

7 April 2018

Glenda Halliday

11

1 reference

7 April 2018

Andrew J. Hughes

9

object named as

Andrew J Hughes

1 reference

7 April 2018

author name string

Jinxia Zhou

1

1 reference

7 April 2018

Melissa Broe

2

1 reference

7 April 2018

John P Anderson

4

1 reference

7 April 2018

Wei-Ping Gai

5

1 reference

7 April 2018

Elizabeth A Milward

6

1 reference

7 April 2018

Michelle Porritt

7

1 reference

7 April 2018

Xiaomin Wang

10

1 reference

7 April 2018

publication date

13 March 2011

1 reference

7 April 2018

published in

Acta Neuropathologica

1 reference

7 April 2018

volume

121

1 reference

7 April 2018

issue

6

1 reference

7 April 2018

page(s)

695-704

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.1007/s00401-011-0815-1

exact match

0 references

cites work

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Are synucleinopathies prion-like disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

α-Synuclein: membrane interactions and toxicity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

alpha-Synuclein and neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Simplified neuropathological diagnosis of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Proteomic identification of novel proteins in cortical lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Enhanced alpha-synuclein expression in human neurodegenerative diseases: pathogenetic and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Missing pieces in the Parkinson's disease puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

The presynaptic particle web: ultrastructure, composition, dissolution, and reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Presynaptic spectrin is essential for synapse stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Accumulation of phosphorylated alpha-synuclein in aging human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

α-Synuclein and DJ-1 as potential biological fluid biomarkers for Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0815-1

10.1007/S00401-011-0815-1

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018